Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lesley M Arnold
Corrections To: Once-Daily Controlled-Release Pregabalin in the Treatment of Patients With Fibromyalgia: A Phase III, Double-Blind, Randomized Withdrawal, Placebo-Controlled Study
Current Medical Research and Opinion
Medicine
Related publications
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Phase III, Randomized, Placebo-Controlled Study of Once-Daily Oral Zibotentan (ZD4054) in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Efficacy of Pregabalin in Post-Traumatic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Journal of Neurology
Neurology
Becaplermin Gel in the Treatment of Pressure Ulcers: A Phase II Randomized, Double-Blind, Placebo-Controlled Study
Wound Repair and Regeneration
Dermatology
Surgery
Effect of Pregabalin on Perioperative Headache in Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Double-Blind, Placebo-Controlled Trial
Journal of Neurosciences in Rural Practice
Neuroscience
Neurology
Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
A Double - Blind, Placebo - Controlled, Randomized Study Comparing Quetiapine With Placebo, Along With Oral Naltrexone, in the Treatment of Opioid Dependent Patients
Journal of Evolution of Medical and Dental Sciences
Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Immunome Research
Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Lipegfilgrastim in Patients With Non-Small Cell Lung Cancer Receiving Myelosuppressive Therapy
SpringerPlus
Multidisciplinary
